Ireland· IE-PA-EU/1/24/1809/010-012

Buprenorphine Neuraxpharm

A buprenorphine product containing buprenorphine hydrochloride, registered in Ireland by Laboratorios Lesvi, S.L.. The same ATC class is registered in 13 of our 19 countries.

ATC N07BC01

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about buprenorphine hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Buprenorphine is registered in 13 of 19 countries.

Countries holding a registration under ATC N07BC01 (buprenorphine), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
9 of them publish a price we can compare per daily dose

Search buprenorphine products by name

Buprenorphine · ATC N07BC01

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of buprenorphine costs, country by country.

Normalised to the WHO defined daily dose (1.6 mg), the median price runs from $1.13 in Switzerland to $4.31 in Spain — a ×3.8 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Buprenorphine · price per daily dose (1.6 mg)

USD · FX 28 Sept 2026

ES Spain$4.31
IT Italy$3.30
CH Switzerland$1.13

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Buprenorphine hydrochloride
Manufacturer: Laboratorios Lesvi, S.L.
Country: Ireland (IE)
ATC code: N07BC01
ATC class: Buprenorphine
Defined daily dose: 1.6 mg, Implantat
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
EU/1/24/1809/010-012

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

376 interactions on record for buprenorphine.

Graded by severity as the source publishes them — 59 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check buprenorphine against other medicines How interaction checks work

Buprenorphine · interactions on record

376 records

59 severe
253 moderate
2 minor
52 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
DronabinolA04AD10severe

10 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Buprenorphine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All buprenorphine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Astec, Bupensan
Belgium · Temgesic, Transtec
Bulgaria · Бупренорфин G.L., Бупренорфин Актавис
Cyprus · Buvera
Czechia · Addnok, Buprenorfin Stada
Germany · Acimaphin, Acinorphin
Denmark · Buprefarm, Bupremyl
Estonia · Buprenorphine G.L. Pharma
Spain · Buprenorfina Andrómaco, Buprenorfina Sandoz
Finland · Buprefarm, Bupremyl
France · Bupensan, Buprenorphine Arrow
United Kingdom (Northern Ireland) · Addnok, Bunov
Greece · Buprenal, Buvera
Croatia · Buprenorfin Alkaloid, Buprenorfin Sandoz
Iceland · Buprenorphine Alvogen, Buprenorphine Neuraxpharm
Italy · Buprenorfina Molteni, Buprenorfina Sandoz
Liechtenstein · Buprenorphine Neuraxpharm, Buvidal
Luxembourg · Temgesic, Temgesic Sublingualis
Latvia · Buprenorphine G.L. Pharma
Malta · Buprenorphine Aspire Pharma (Malta), Natzon
Netherlands · Buprenorfine, Buprenorfine 1a Pharma
Norway · Bugnanto, Buprefarm
Poland · Bunondol, Bunorfin
Portugal · Buprenorfina, Buprenorfina Aurovitas
Sweden · Buprefarm, Buprenorfin Actavis
Slovenia · Addnok, Buprenorfin Alkaloid-Int
Slovakia · Bupretec, Noprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ae47dc2c-8ac0-4fb3-a679-854aae503bfa
GET /v1/drugs/ae47dc2c-8ac0-4fb3-a679-854aae503bfa?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Sublingual film",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N07BC01"
  ],
  "strength": null,
  "pa_number": "EU/1/24/1809/010-012",
  "substances": [
    "Buprenorphine hydrochloride"
  ],
  "legal_basis": "Hybrid application (Article 10(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "19/12/2024",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about buprenorphine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console